Advancing Pharmaceutical Delivery for Better Patient Outcomes
EVE is an Australian health innovation company
Through proprietary solubility and delivery systems, Eve Health Group transforms how pharmaceuticals and nutraceuticals are absorbed, improving efficacy and consumer experience
EVE Health Group (ASX: EVE) has just completed the acquisition of Nextract Pty Ltd, a biotech innovator advancing solubility-enhancing drug delivery systems for regulated pharmaceuticals and nutraceuticals.
WHAT'S NEW
TeleDocs Partnership
EVE and Teledocs Clinic sign national prescribing agreement for the future prescribing and promotion of EVE's lead pharmaceutical products targeting men's and women's health.
.png){kind=icon}
.png){kind=icon}
%20(2).png)
%20(3).png)